Fayez Sarofim & CO Merck & Co., Inc. Transaction History

Fayez Sarofim & CO

$38.7 Billion
Q3 2024

A detailed history of Fayez Sarofim & CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fayez Sarofim & CO holds 2,895,191 shares of MRK stock, worth $287 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

2,895,191

Previous 2,921,940 0.92%

Holding current value

$287 Million

Previous $362 Million 9.11%

% of portfolio

0.85%

Previous 0.99%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $2.97 Million - $3.45 Million	-26,749 Reduced 0.92%	2,895,191 $329 Million
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $88.9 Million - $95.5 Million	718,344 Added 32.6%	2,921,940 $362 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $23.7 Million - $27.6 Million	-209,455 Reduced 8.68%	2,203,596 $291 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $5.03 Million - $5.47 Million	-50,206 Reduced 2.04%	2,413,051 $263 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $6.96 Million - $7.73 Million	67,646 Added 2.82%	2,463,257 $254 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $98.3 Million - $107 Million	-904,765 Reduced 27.41%	2,395,611 $276 Million
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $13.5 Million - $15.1 Million	-131,058 Reduced 3.82%	3,300,376 $351 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $2.75 Million - $3.52 Million	-31,423 Reduced 0.91%	3,431,434 $381 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $57,395 - $64,477	-679 Reduced 0.02%	3,462,857 $298 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $300,730 - $340,893	3,602 Added 0.1%	3,463,536 $316 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $103,575 - $116,101	1,409 Added 0.04%	3,459,934 $284 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $3.51 Million - $4.39 Million	48,504 Added 1.42%	3,458,525 $265 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $227,727 - $250,442	-3,177 Reduced 0.09%	3,410,021 $256 Million
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $725,177 - $802,119	-10,314 Reduced 0.3%	3,413,198 $265 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $7.03 Million - $8.28 Million	102,089 Added 3.07%	3,423,512 $264 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $4.1 Million - $4.55 Million	57,096 Added 1.75%	3,321,423 $272 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $1.74 Million - $1.97 Million	23,740 Added 0.73%	3,264,327 $271 Million
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $343,156 - $390,473	4,873 Added 0.15%	3,240,587 $251 Million
Q1 2020 May 12, 2020	BUY	$63.36 - $87.82 $6.46 Million - $8.96 Million	102,026 Added 3.26%	3,235,714 $249 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $2.17 Million - $2.45 Million	28,016 Added 0.9%	3,133,688 $285 Million
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $1.75 Million - $1.91 Million	23,044 Added 0.75%	3,105,672 $261 Million
Q2 2019 Aug 09, 2019	BUY	$69.84 - $81.59 $5.9 Million - $6.89 Million	84,446 Added 2.82%	3,082,628 $258 Million
Q1 2019 May 14, 2019	BUY	$69.58 - $79.36 $1.45 Million - $1.66 Million	20,886 Added 0.7%	2,998,182 $249 Million
Q4 2018 Feb 13, 2019	BUY	$65.24 - $75.71 $3.1 Million - $3.59 Million	47,467 Added 1.62%	2,977,296 $227 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $567,381 - $667,206	9,835 Added 0.34%	2,929,829 $208 Million
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $2.37 Million - $2.78 Million	46,608 Added 1.62%	2,919,994 $177 Million
Q1 2018 May 10, 2018	SELL	$50.96 - $59.23 $2.37 Million - $2.76 Million	-46,534 Reduced 1.59%	2,873,386 $157 Million
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $2.95 Million - $3.52 Million	-57,118 Reduced 1.92%	2,919,920 $164 Million
Q3 2017 Nov 08, 2017	BUY	$58.67 - $63.13 $175 Million - $188 Million	2,977,038	2,977,038 $191 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Account